What Is Spravato®?
Spravato® nasal spray is a groundbreaking therapy that can provide rapid relief from severe depression using a ketamine derivative called esketamine.
In 2019, Spravato® was approved by the FDA to provide relief for those suffering from treatment-resistant depression (TRD).
Unlike traditional antidepressants, it acts rapidly by targeting specific brain receptors, providing relief for individuals who have not responded to conventional treatments. Spravato is administered under medical supervision and is often combined with oral antidepressants for enhanced effectiveness. Many insurance plans cover Spravato®, making it a more accessible option for those in need of advanced depression treatment.
The Benefits of Spravato
-
Rapid Relief – Many patients begin to feel better within hours or days—far faster than traditional antidepressants, which can take weeks to show results.
-
Simple & Non-Invasive – Spravato is a nasal spray. No needles or IVs—just inhale, relax, and let the treatment work while you rest in our calming New Rochelle clinic.
-
A Different Approach – Spravato targets the brain in a unique way, offering hope when other depression treatments haven’t worked.
-
Insurance Coverage – For those diagnosed with treatment-resistant depression, Spravato is FDA-approved and typically covered by insurance, making advanced care accessible to patients across Westchester County and the greater New York area.
To find out if Spravato is right for you, schedule a free consultation with our doctor:
Who Can Be Treated With Spravato?
Spravato is specifically designed for individuals suffering from:
Major Depressive Disorder (MDD) with Suicidal Ideation
If you suffer from severe depressive episodes with suicidal thoughts, Spravato can offer effective symptom relief.
Bipolar Disorder
Characterized by extreme mood swings, including mania and depression. Spravato® helps manage bipolar depression when other treatments fail.
Anxiety Disorders
Severe anxiety can disrupt daily life. Spravato® may help those who don’t respond to traditional treatments.
Treatment-Resistant Depression (TRD)
If you’ve tried two or more antidepressant treatments without success, Spravato may be the solution you’ve been looking for.
PTSD (Post-Traumatic Stress Disorder)
A condition triggered by trauma, leading to flashbacks and anxiety. Spravato® helps reduce PTSD symptoms and restore emotional balance.
Alcohol Addiction
Alcohol dependence affects mental and physical health. Spravato® may help reduce cravings and support recovery.
OCD (Obsessive-Compulsive Disorder)
Intrusive thoughts and repetitive behaviors can be debilitating. Spravato® is being explored as an alternative treatment for severe OCD.
Frequently Asked Question - FAQ's
What is Spravato® and how does it work?
Spravato® (esketamine) is an FDA-approved nasal spray derived from ketamine for the treatment of treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal thoughts. It targets NMDA receptors in the brain, helping to rapidly relieve depressive symptoms when other medications have failed.
Who is eligible for Spravato® treatment?
Spravato is typically prescribed for adults with treatment-resistant depression or major depressive disorder with suicidal ideation. Patients must receive care at a certified Spravato treatment center under the supervision of a qualified healthcare provider.
How is Spravato® administered?
Spravato is a nasal spray self-administered in the clinic under direct medical supervision. After each dose, patients relax in a private room while trained staff monitor blood pressure, heart rate, and other vital signs for at least two hours to ensure safety.
How quickly does Spravato® work?
Many patients notice a reduction in depressive symptoms within hours or days of their first session—much faster than traditional antidepressants, which can take weeks to show results.
What are the potential side effects of Spravato®?
Possible side effects may include dizziness, dissociation, nausea, drowsiness, or temporary increases in blood pressure. Because of these effects, patients should not drive or operate machinery until the day after treatment.
How often will I need Spravato® treatments?
Treatment frequency varies by individual, but most people begin with two sessions per week for the first month, followed by a gradual taper based on progress and provider recommendations.
Insurance Coverage
Ketamine Nasal Spray – Esketamine (Spravato) is covered by most insurance plans and Fuse Mind & Body accepts Medicare and most commercial health plans. (We do not currently accept Medicaid.)
Our administrative team can help verify your insurance benefits and determine your level of coverage. Simply email a copy of the front and back of your insurance card along with your date of birth to info@fusemindbody.com, and we’ll confirm your eligibility.
Additionally, Janssen—the manufacturer of Spravato—offers a patient assistance program that can help reduce out-of-pocket costs, including copays, coinsurance, and deductibles. Our staff will guide you through the process and handle the paperwork on your behalf.
See if Ketamine Is Right For You
Life is hectic, and we get it. That’s why Fuse Mind & Body offers evening and weekend hours that work with your schedule. Our welcoming team is here to answer questions and provide guidance every step of the way as you begin your ketamine therapy journey.
